Us Bancorp \De\ Heron Therapeutics, Inc. Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$2.66 - $5.37 $11,182 - $22,575	4,204 New	4,204 $18,000
Q2 2021 Aug 05, 2021	SELL	$13.27 - $18.48 $4,644 - $6,468	-350 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$14.61 - $22.14 $978 - $1,483	67 Added 23.67%	350 $7,000
Q2 2020 Aug 07, 2020	SELL	$10.89 - $21.47 $2,363 - $4,658	-217 Reduced 43.4%	283 $4,000
Q1 2020 May 13, 2020	BUY	$10.23 - $24.56 $3,069 - $7,368	300 Added 150.0%	500 $6,000
Q3 2019 Nov 08, 2019	SELL	$16.36 - $21.39 $63,934 - $83,592	-3,908 Reduced 95.13%	200 $4,000
Q2 2019 Aug 13, 2019	BUY	$16.93 - $26.22 $29,949 - $46,383	1,769 Added 75.63%	4,108 $76,000
Q1 2019 May 08, 2019	BUY	$23.15 - $28.34 $54,147 - $66,287	2,339 New	2,339 $57,000

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $194M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.